

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | barbed-end actin filament capping (GO:0051016) | 5.01248630 |
| 2 | NADH metabolic process (GO:0006734) | 4.65602439 |
| 3 | synaptic vesicle exocytosis (GO:0016079) | 4.56024225 |
| 4 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.54583246 |
| 5 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.49716382 |
| 6 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.30146333 |
| 7 | synaptic vesicle maturation (GO:0016188) | 4.27636587 |
| 8 | protein maturation by protein folding (GO:0022417) | 4.21219967 |
| 9 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.16939101 |
| 10 | ATP synthesis coupled proton transport (GO:0015986) | 4.16939101 |
| 11 | fibril organization (GO:0097435) | 4.12628684 |
| 12 | COPI coating of Golgi vesicle (GO:0048205) | 4.10939017 |
| 13 | Golgi transport vesicle coating (GO:0048200) | 4.10939017 |
| 14 | protein localization to endosome (GO:0036010) | 4.04612463 |
| 15 | vocalization behavior (GO:0071625) | 3.98773290 |
| 16 | neuronal action potential propagation (GO:0019227) | 3.98741781 |
| 17 | positive regulation of receptor recycling (GO:0001921) | 3.92457871 |
| 18 | extracellular fibril organization (GO:0043206) | 3.92340873 |
| 19 | glutamate secretion (GO:0014047) | 3.90451191 |
| 20 | respiratory electron transport chain (GO:0022904) | 3.82084493 |
| 21 | electron transport chain (GO:0022900) | 3.74012805 |
| 22 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.71438823 |
| 23 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 3.68961280 |
| 24 | stress fiber assembly (GO:0043149) | 3.66046666 |
| 25 | protein retention in ER lumen (GO:0006621) | 3.64197943 |
| 26 | negative regulation of protein localization to plasma membrane (GO:1903077) | 3.64017251 |
| 27 | protein localization to synapse (GO:0035418) | 3.63891854 |
| 28 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.60046952 |
| 29 | neuron cell-cell adhesion (GO:0007158) | 3.52768113 |
| 30 | glycosphingolipid catabolic process (GO:0046479) | 3.50492173 |
| 31 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.49464262 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.46830650 |
| 33 | locomotory exploration behavior (GO:0035641) | 3.40614765 |
| 34 | neurotransmitter secretion (GO:0007269) | 3.39744770 |
| 35 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.39711214 |
| 36 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.38903123 |
| 37 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.38903123 |
| 38 | regulation of synapse structural plasticity (GO:0051823) | 3.35519070 |
| 39 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.32199563 |
| 40 | glycolipid catabolic process (GO:0019377) | 3.30257601 |
| 41 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 3.30235657 |
| 42 | regulation of synaptic vesicle transport (GO:1902803) | 3.30111160 |
| 43 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.27934171 |
| 44 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 3.27362936 |
| 45 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.26226563 |
| 46 | regulation of glutamate secretion (GO:0014048) | 3.24292962 |
| 47 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.24258055 |
| 48 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.22432403 |
| 49 | alpha-linolenic acid metabolic process (GO:0036109) | 3.20272459 |
| 50 | regulation of early endosome to late endosome transport (GO:2000641) | 3.18247421 |
| 51 | proline transport (GO:0015824) | 3.16694806 |
| 52 | adenosine receptor signaling pathway (GO:0001973) | 3.14757612 |
| 53 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.13902840 |
| 54 | protein hydroxylation (GO:0018126) | 3.13279796 |
| 55 | peptidyl-proline hydroxylation (GO:0019511) | 3.11343165 |
| 56 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.08989350 |
| 57 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.07835311 |
| 58 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.07518631 |
| 59 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.07257393 |
| 60 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.07226285 |
| 61 | type B pancreatic cell proliferation (GO:0044342) | 3.07131015 |
| 62 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.05774204 |
| 63 | cellular potassium ion homeostasis (GO:0030007) | 3.04562096 |
| 64 | regulation of vesicle fusion (GO:0031338) | 3.04102404 |
| 65 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.02422748 |
| 66 | negative regulation of cation channel activity (GO:2001258) | 3.02290829 |
| 67 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.01421635 |
| 68 | neuron-neuron synaptic transmission (GO:0007270) | 3.00681362 |
| 69 | beta-amyloid metabolic process (GO:0050435) | 2.96518940 |
| 70 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.96474661 |
| 71 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.94901021 |
| 72 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.94861765 |
| 73 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.93994273 |
| 74 | synaptic transmission, glutamatergic (GO:0035249) | 2.93042637 |
| 75 | pentose-phosphate shunt (GO:0006098) | 2.87998738 |
| 76 | pinocytosis (GO:0006907) | 2.87627309 |
| 77 | synaptic transmission, dopaminergic (GO:0001963) | 2.86857123 |
| 78 | negative regulation of adherens junction organization (GO:1903392) | 2.86222041 |
| 79 | negative regulation of focal adhesion assembly (GO:0051895) | 2.86222041 |
| 80 | negative regulation of cell junction assembly (GO:1901889) | 2.86222041 |
| 81 | layer formation in cerebral cortex (GO:0021819) | 2.85654519 |
| 82 | triglyceride catabolic process (GO:0019433) | 2.85029081 |
| 83 | low-density lipoprotein particle clearance (GO:0034383) | 2.82690765 |
| 84 | neurotransmitter transport (GO:0006836) | 2.81142367 |
| 85 | transferrin transport (GO:0033572) | 2.80429264 |
| 86 | hydrogen ion transmembrane transport (GO:1902600) | 2.80215430 |
| 87 | exploration behavior (GO:0035640) | 2.79633712 |
| 88 | regulation of protein kinase A signaling (GO:0010738) | 2.78822630 |
| 89 | activation of protein kinase A activity (GO:0034199) | 2.78059198 |
| 90 | regulation of receptor recycling (GO:0001919) | 2.76892811 |
| 91 | negative regulation of amino acid transport (GO:0051956) | 2.75752090 |
| 92 | mating behavior (GO:0007617) | 2.75556913 |
| 93 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.75442631 |
| 94 | gamma-aminobutyric acid transport (GO:0015812) | 2.73439428 |
| 95 | glutamate receptor signaling pathway (GO:0007215) | 2.71996676 |
| 96 | response to thyroid hormone (GO:0097066) | 2.70668190 |
| 97 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.70423272 |
| 98 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.70374655 |
| 99 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.69608349 |
| 100 | behavioral response to cocaine (GO:0048148) | 2.69157455 |
| 101 | negative regulation of peptidyl-threonine phosphorylation (GO:0010801) | 2.68072816 |
| 102 | skin morphogenesis (GO:0043589) | 2.67663375 |
| 103 | tricarboxylic acid cycle (GO:0006099) | 2.67378268 |
| 104 | regulation of neurotransmitter levels (GO:0001505) | 2.66763645 |
| 105 | chaperone-mediated protein transport (GO:0072321) | 2.66328511 |
| 106 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 2.66075954 |
| 107 | deoxyribose phosphate biosynthetic process (GO:0046385) | 2.66075954 |
| 108 | neuromuscular process controlling posture (GO:0050884) | 2.65729620 |
| 109 | NADPH regeneration (GO:0006740) | 2.64391949 |
| 110 | positive regulation of membrane potential (GO:0045838) | 2.64175746 |
| 111 | negative regulation of dendrite morphogenesis (GO:0050774) | 2.64006958 |
| 112 | acylglycerol catabolic process (GO:0046464) | 2.63922916 |
| 113 | neutral lipid catabolic process (GO:0046461) | 2.63922916 |
| 114 | regulation of low-density lipoprotein particle receptor biosynthetic process (GO:0045714) | 2.63818651 |
| 115 | long-term memory (GO:0007616) | 2.63078171 |
| 116 | tricarboxylic acid metabolic process (GO:0072350) | 2.62156901 |
| 117 | trivalent inorganic cation transport (GO:0072512) | 2.62142809 |
| 118 | ferric iron transport (GO:0015682) | 2.62142809 |
| 119 | ATP biosynthetic process (GO:0006754) | 2.61944533 |
| 120 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.61579939 |
| 121 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.61579939 |
| 122 | cyclooxygenase pathway (GO:0019371) | 2.59600858 |
| 123 | nitrogen cycle metabolic process (GO:0071941) | 2.59119291 |
| 124 | positive regulation of Rho protein signal transduction (GO:0035025) | 2.59064150 |
| 125 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.58980466 |
| 126 | neuron recognition (GO:0008038) | 2.58924175 |
| 127 | negative regulation of establishment of protein localization to plasma membrane (GO:0090005) | 2.58100794 |
| 128 | GDP-mannose metabolic process (GO:0019673) | 2.57747695 |
| 129 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.57094884 |
| 130 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.56508724 |
| 131 | negative regulation of necroptotic process (GO:0060546) | 2.56436424 |
| 132 | protein neddylation (GO:0045116) | 2.55723128 |
| 133 | detection of calcium ion (GO:0005513) | 2.54768098 |
| 134 | platelet aggregation (GO:0070527) | 2.54184979 |
| 135 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.54031982 |
| 136 | proton transport (GO:0015992) | 2.53885051 |
| 137 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.53744527 |
| 138 | positive regulation of lamellipodium assembly (GO:0010592) | 2.53263151 |
| 139 | ceramide catabolic process (GO:0046514) | 2.53121813 |
| 140 | regulation of necrotic cell death (GO:0010939) | 2.52936762 |
| 141 | regulation of protein localization to plasma membrane (GO:1903076) | 2.51959842 |
| 142 | transmission of nerve impulse (GO:0019226) | 2.51441852 |
| 143 | hydrogen transport (GO:0006818) | 2.51305789 |
| 144 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.50905106 |
| 145 | cellular response to epinephrine stimulus (GO:0071872) | 2.49700349 |
| 146 | urea cycle (GO:0000050) | 2.49626497 |
| 147 | platelet degranulation (GO:0002576) | 2.49590366 |
| 148 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.48908183 |
| 149 | positive regulation of neurotransmitter transport (GO:0051590) | 2.48386009 |
| 150 | fibroblast migration (GO:0010761) | 2.48298061 |
| 151 | regulation of necroptotic process (GO:0060544) | 2.47916935 |
| 152 | oxaloacetate metabolic process (GO:0006107) | 2.47794674 |
| 153 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.47738670 |
| 154 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.47502404 |
| 155 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.47413545 |
| 156 | dendritic spine morphogenesis (GO:0060997) | 2.47371255 |
| 157 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 2.47325405 |
| 158 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.47202877 |
| 159 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.47202877 |
| 160 | long-term synaptic potentiation (GO:0060291) | 2.46279601 |
| 161 | regulation of postsynaptic membrane potential (GO:0060078) | 2.45781444 |
| 162 | positive regulation of cellular response to insulin stimulus (GO:1900078) | 2.45659976 |
| 163 | positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling | 2.45161606 |
| 164 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | 2.45161606 |
| 165 | glucose catabolic process (GO:0006007) | 2.44434483 |
| 166 | substantia nigra development (GO:0021762) | 2.44250573 |
| 167 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.44239177 |
| 168 | regulation of cell communication by electrical coupling (GO:0010649) | 2.44048503 |
| 169 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.43614675 |
| 170 | regulation of synaptic plasticity (GO:0048167) | 2.41858235 |
| 171 | muscle cell migration (GO:0014812) | 2.41320232 |
| 172 | response to histamine (GO:0034776) | 2.40895412 |
| 173 | calcium ion-dependent exocytosis (GO:0017156) | 2.40684925 |
| 174 | localization within membrane (GO:0051668) | 2.40638766 |
| 175 | apoptotic cell clearance (GO:0043277) | 2.40485490 |
| 176 | mitochondrial calcium ion homeostasis (GO:0051560) | 2.40413441 |
| 177 | regulation of dopamine metabolic process (GO:0042053) | 2.40228286 |
| 178 | regulation of catecholamine metabolic process (GO:0042069) | 2.40228286 |
| 179 | cortical actin cytoskeleton organization (GO:0030866) | 2.39727302 |
| 180 | protein targeting to plasma membrane (GO:0072661) | 2.39007954 |
| 181 | regulation of neurotransmitter secretion (GO:0046928) | 2.38871330 |
| 182 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.37452353 |
| 183 | response to amphetamine (GO:0001975) | 2.37136213 |
| 184 | negative regulation of microtubule polymerization (GO:0031115) | 2.37030417 |
| 185 | cellular copper ion homeostasis (GO:0006878) | 2.36901073 |
| 186 | vesicle coating (GO:0006901) | 2.36714223 |
| 187 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.36399564 |
| 188 | prepulse inhibition (GO:0060134) | 2.36033249 |
| 189 | UV protection (GO:0009650) | 2.33142774 |
| 190 | negative regulation of cell size (GO:0045792) | 2.32181165 |
| 191 | epithelial cell-cell adhesion (GO:0090136) | 2.30834717 |
| 192 | mitochondrial fusion (GO:0008053) | 2.30185047 |
| 193 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.29362362 |
| 194 | positive regulation of lamellipodium organization (GO:1902745) | 2.29191528 |
| 195 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.28616145 |
| 196 | clathrin coat assembly (GO:0048268) | 2.28367825 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.68202969 |
| 2 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.85588848 |
| 3 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.51805615 |
| 4 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.12758988 |
| 5 | CLOCK_20551151_ChIP-Seq_293T_Human | 3.12615273 |
| 6 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.11927525 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.09917441 |
| 8 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.96305798 |
| 9 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.91789166 |
| 10 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.73470672 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.66451343 |
| 12 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.63589013 |
| 13 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.62994041 |
| 14 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.60509780 |
| 15 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.58292333 |
| 16 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.56807401 |
| 17 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.51240152 |
| 18 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.51115455 |
| 19 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.49515180 |
| 20 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.44313365 |
| 21 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.44313365 |
| 22 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.40832740 |
| 23 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.38705040 |
| 24 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.37907217 |
| 25 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.37508526 |
| 26 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33103742 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.27825397 |
| 28 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.24817067 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.17681954 |
| 30 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.10682526 |
| 31 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10382412 |
| 32 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 2.05133437 |
| 33 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.00221327 |
| 34 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.89968241 |
| 35 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.87923048 |
| 36 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.84451723 |
| 37 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.83862468 |
| 38 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.82342960 |
| 39 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79519622 |
| 40 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.78190571 |
| 41 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.77120942 |
| 42 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.72879950 |
| 43 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.71939533 |
| 44 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.69743890 |
| 45 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.69545419 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.68496063 |
| 47 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.68259296 |
| 48 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.66764450 |
| 49 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.63899106 |
| 50 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.63364959 |
| 51 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.62993725 |
| 52 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.62747532 |
| 53 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.62716420 |
| 54 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.62427565 |
| 55 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.58056768 |
| 56 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.57915803 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.57656967 |
| 58 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56564421 |
| 59 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.51840538 |
| 60 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.51796955 |
| 61 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.50975995 |
| 62 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.50904657 |
| 63 | * THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.48685704 |
| 64 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.48638770 |
| 65 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.48399104 |
| 66 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.48355182 |
| 67 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.47933051 |
| 68 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47578841 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.47470552 |
| 70 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.47048997 |
| 71 | * HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.46253712 |
| 72 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.45860597 |
| 73 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.43515491 |
| 74 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.42628632 |
| 75 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.41182532 |
| 76 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39261112 |
| 77 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.38801066 |
| 78 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.37896993 |
| 79 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.37002876 |
| 80 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.35507701 |
| 81 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.35295944 |
| 82 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.33648451 |
| 83 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.32478689 |
| 84 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.32155160 |
| 85 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.31219096 |
| 86 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31218695 |
| 87 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.30305342 |
| 88 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30274732 |
| 89 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.29061472 |
| 90 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 1.28203607 |
| 91 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.27153974 |
| 92 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.24653249 |
| 93 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.23715426 |
| 94 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.23715426 |
| 95 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.23616340 |
| 96 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.23184395 |
| 97 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.23096544 |
| 98 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.22634886 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 1.20974757 |
| 100 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.20971491 |
| 101 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.20799831 |
| 102 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18156158 |
| 103 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.17493033 |
| 104 | * GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.17444480 |
| 105 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.17152457 |
| 106 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16785814 |
| 107 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.16430478 |
| 108 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.16184566 |
| 109 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.16151653 |
| 110 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.15191520 |
| 111 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.14705646 |
| 112 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.13219343 |
| 113 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.12120261 |
| 114 | AR_25329375_ChIP-Seq_VCAP_Human | 1.11694383 |
| 115 | EOMES_21245162_ChIP-Seq_HESCs_Human | 1.11347144 |
| 116 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.11292966 |
| 117 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11172945 |
| 118 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.10955915 |
| 119 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.10955915 |
| 120 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.09873406 |
| 121 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.09659251 |
| 122 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.09531506 |
| 123 | ATF3_27146783_Chip-Seq_COLON_Human | 1.09319283 |
| 124 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.08454464 |
| 125 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 1.06474471 |
| 126 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.06260357 |
| 127 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.05959861 |
| 128 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.05774388 |
| 129 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.05660956 |
| 130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.04827691 |
| 131 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.04770338 |
| 132 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.04245301 |
| 133 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04226769 |
| 134 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.04060035 |
| 135 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.02685554 |
| 136 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.02563302 |
| 137 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.02524142 |
| 138 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 1.02434294 |
| 139 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.02011118 |
| 140 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.01666329 |
| 141 | JUN_21703547_ChIP-Seq_K562_Human | 1.00978331 |
| 142 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.00125383 |
| 143 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.98929526 |
| 144 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.97487854 |
| 145 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.97142717 |
| 146 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.96193903 |
| 147 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.95248119 |
| 148 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.95181456 |
| 149 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94711842 |
| 150 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.94671814 |
| 151 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.94485062 |
| 152 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.94183477 |
| 153 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94055484 |
| 154 | GATA1_19941826_ChIP-Seq_K562_Human | 0.93670024 |
| 155 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.93597182 |
| 156 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 0.93244146 |
| 157 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93128361 |
| 158 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.93037692 |
| 159 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.92994722 |
| 160 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.92682399 |
| 161 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.92039817 |
| 162 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.91643650 |
| 163 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.91275469 |
| 164 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.91197270 |
| 165 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.90687709 |
| 166 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90350868 |
| 167 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.89357154 |
| 168 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88175400 |
| 169 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.87649578 |
| 170 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.86901034 |
| 171 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85926406 |
| 172 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.83489385 |
| 173 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.82522227 |
| 174 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.80477354 |
| 175 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.79079387 |
| 176 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.77024248 |
| 177 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.74425843 |
| 178 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.74228255 |
| 179 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 0.74157155 |
| 180 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.73745667 |
| 181 | * TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.73506055 |
| 182 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.72864188 |
| 183 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.72864188 |
| 184 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.71282074 |
| 185 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.70839619 |
| 186 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.70839384 |
| 187 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.70553270 |
| 188 | NANOG_19829295_ChIP-Seq_ESCs_Human | 0.69621536 |
| 189 | SOX2_19829295_ChIP-Seq_ESCs_Human | 0.69621536 |
| 190 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.68231865 |
| 191 | FUS_26573619_Chip-Seq_HEK293_Human | 0.67878426 |
| 192 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.66850583 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.51830147 |
| 2 | MP0003880_abnormal_central_pattern | 4.38624862 |
| 3 | MP0004270_analgesia | 3.83032846 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.58185837 |
| 5 | MP0002822_catalepsy | 3.33929664 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 3.28561797 |
| 7 | MP0001968_abnormal_touch/_nociception | 3.27799172 |
| 8 | MP0009745_abnormal_behavioral_response | 2.97376774 |
| 9 | MP0002064_seizures | 2.86095678 |
| 10 | MP0002736_abnormal_nociception_after | 2.85359453 |
| 11 | MP0002734_abnormal_mechanical_nocicepti | 2.83330105 |
| 12 | MP0003191_abnormal_cellular_cholesterol | 2.74396964 |
| 13 | MP0002877_abnormal_melanocyte_morpholog | 2.68733721 |
| 14 | MP0005464_abnormal_platelet_physiology | 2.64229380 |
| 15 | MP0002063_abnormal_learning/memory/cond | 2.63770848 |
| 16 | MP0004185_abnormal_adipocyte_glucose | 2.63449624 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.61448986 |
| 18 | MP0005423_abnormal_somatic_nervous | 2.60812853 |
| 19 | MP0005451_abnormal_body_composition | 2.59802728 |
| 20 | MP0009046_muscle_twitch | 2.59621763 |
| 21 | MP0000343_altered_response_to | 2.50787219 |
| 22 | MP0005670_abnormal_white_adipose | 2.50235995 |
| 23 | MP0003566_abnormal_cell_adhesion | 2.47448477 |
| 24 | MP0008260_abnormal_autophagy | 2.44376729 |
| 25 | MP0005666_abnormal_adipose_tissue | 2.41420233 |
| 26 | MP0006276_abnormal_autonomic_nervous | 2.40914753 |
| 27 | MP0002572_abnormal_emotion/affect_behav | 2.37220896 |
| 28 | MP0003186_abnormal_redox_activity | 2.35085086 |
| 29 | MP0001440_abnormal_grooming_behavior | 2.34557112 |
| 30 | MP0001905_abnormal_dopamine_level | 2.31038782 |
| 31 | MP0002272_abnormal_nervous_system | 2.29547885 |
| 32 | MP0009840_abnormal_foam_cell | 2.26271596 |
| 33 | MP0002733_abnormal_thermal_nociception | 2.20861894 |
| 34 | MP0008438_abnormal_cutaneous_collagen | 2.19385528 |
| 35 | MP0001970_abnormal_pain_threshold | 2.16777199 |
| 36 | MP0001529_abnormal_vocalization | 2.16217075 |
| 37 | MP0004233_abnormal_muscle_weight | 1.99917117 |
| 38 | MP0003329_amyloid_beta_deposits | 1.97227048 |
| 39 | MP0001849_ear_inflammation | 1.95093958 |
| 40 | MP0009379_abnormal_foot_pigmentation | 1.94189713 |
| 41 | MP0001501_abnormal_sleep_pattern | 1.91205187 |
| 42 | MP0001486_abnormal_startle_reflex | 1.85500838 |
| 43 | MP0002837_dystrophic_cardiac_calcinosis | 1.85101157 |
| 44 | MP0000749_muscle_degeneration | 1.83590641 |
| 45 | MP0004130_abnormal_muscle_cell | 1.83017284 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.79560943 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.75799072 |
| 48 | MP0002971_abnormal_brown_adipose | 1.75749283 |
| 49 | MP0002067_abnormal_sensory_capabilities | 1.73338130 |
| 50 | MP0001958_emphysema | 1.71369991 |
| 51 | MP0010386_abnormal_urinary_bladder | 1.67603830 |
| 52 | MP0000747_muscle_weakness | 1.67031792 |
| 53 | MP0004924_abnormal_behavior | 1.65699671 |
| 54 | MP0005386_behavior/neurological_phenoty | 1.65699671 |
| 55 | MP0000013_abnormal_adipose_tissue | 1.57883657 |
| 56 | MP0010352_gastrointestinal_tract_polyps | 1.50752688 |
| 57 | MP0005257_abnormal_intraocular_pressure | 1.49335906 |
| 58 | MP0003806_abnormal_nucleotide_metabolis | 1.48204260 |
| 59 | MP0003828_pulmonary_edema | 1.45236951 |
| 60 | MP0003221_abnormal_cardiomyocyte_apopto | 1.40521317 |
| 61 | MP0004858_abnormal_nervous_system | 1.40116129 |
| 62 | MP0002557_abnormal_social/conspecific_i | 1.39864329 |
| 63 | MP0004142_abnormal_muscle_tone | 1.37310018 |
| 64 | MP0001984_abnormal_olfaction | 1.36917255 |
| 65 | MP0005501_abnormal_skin_physiology | 1.35871651 |
| 66 | MP0002184_abnormal_innervation | 1.34086366 |
| 67 | MP0000751_myopathy | 1.32809085 |
| 68 | MP0003879_abnormal_hair_cell | 1.32785589 |
| 69 | MP0009780_abnormal_chondrocyte_physiolo | 1.32576621 |
| 70 | MP0002796_impaired_skin_barrier | 1.32470525 |
| 71 | MP0003279_aneurysm | 1.32021225 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.31899033 |
| 73 | MP0003091_abnormal_cell_migration | 1.28335350 |
| 74 | MP0004811_abnormal_neuron_physiology | 1.27791347 |
| 75 | MP0001542_abnormal_bone_strength | 1.26426531 |
| 76 | MP0000858_altered_metastatic_potential | 1.26344647 |
| 77 | MP0000604_amyloidosis | 1.25719329 |
| 78 | MP0003633_abnormal_nervous_system | 1.23622513 |
| 79 | MP0004087_abnormal_muscle_fiber | 1.23621956 |
| 80 | MP0005535_abnormal_body_temperature | 1.23163184 |
| 81 | MP0002066_abnormal_motor_capabilities/c | 1.20830915 |
| 82 | MP0005167_abnormal_blood-brain_barrier | 1.19886515 |
| 83 | MP0008569_lethality_at_weaning | 1.18848077 |
| 84 | MP0003656_abnormal_erythrocyte_physiolo | 1.18188654 |
| 85 | MP0004084_abnormal_cardiac_muscle | 1.17057333 |
| 86 | MP0003868_abnormal_feces_composition | 1.16800330 |
| 87 | MP0001727_abnormal_embryo_implantation | 1.16752688 |
| 88 | MP0000920_abnormal_myelination | 1.15192306 |
| 89 | MP0000003_abnormal_adipose_tissue | 1.14686702 |
| 90 | MP0004147_increased_porphyrin_level | 1.10172224 |
| 91 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.09605650 |
| 92 | MP0000759_abnormal_skeletal_muscle | 1.09074718 |
| 93 | MP0005275_abnormal_skin_tensile | 1.08179465 |
| 94 | MP0000778_abnormal_nervous_system | 1.06641273 |
| 95 | MP0003122_maternal_imprinting | 1.06274889 |
| 96 | MP0006138_congestive_heart_failure | 1.05788139 |
| 97 | MP0009115_abnormal_fat_cell | 1.05220910 |
| 98 | MP0004272_abnormal_basement_membrane | 1.03980642 |
| 99 | MP0002876_abnormal_thyroid_physiology | 1.03025945 |
| 100 | MP0008872_abnormal_physiological_respon | 1.02487722 |
| 101 | MP0002882_abnormal_neuron_morphology | 1.02285150 |
| 102 | MP0005023_abnormal_wound_healing | 0.98495282 |
| 103 | MP0001243_abnormal_dermal_layer | 0.98021174 |
| 104 | MP0004885_abnormal_endolymph | 0.98016203 |
| 105 | MP0002896_abnormal_bone_mineralization | 0.97843786 |
| 106 | MP0008874_decreased_physiological_sensi | 0.97600229 |
| 107 | MP0005330_cardiomyopathy | 0.97491321 |
| 108 | MP0000955_abnormal_spinal_cord | 0.97384880 |
| 109 | MP0003075_altered_response_to | 0.97033533 |
| 110 | MP0002970_abnormal_white_adipose | 0.96477892 |
| 111 | MP0003631_nervous_system_phenotype | 0.96371321 |
| 112 | MP0005646_abnormal_pituitary_gland | 0.95659976 |
| 113 | MP0004215_abnormal_myocardial_fiber | 0.94972586 |
| 114 | MP0002269_muscular_atrophy | 0.93220275 |
| 115 | MP0005645_abnormal_hypothalamus_physiol | 0.92830880 |
| 116 | MP0001661_extended_life_span | 0.91936010 |
| 117 | MP0008004_abnormal_stomach_pH | 0.91659154 |
| 118 | MP0003303_peritoneal_inflammation | 0.90883769 |
| 119 | MP0004043_abnormal_pH_regulation | 0.88604006 |
| 120 | MP0004484_altered_response_of | 0.87721790 |
| 121 | MP0000230_abnormal_systemic_arterial | 0.87656022 |
| 122 | MP0004085_abnormal_heartbeat | 0.87406724 |
| 123 | MP0003690_abnormal_glial_cell | 0.86444826 |
| 124 | MP0003638_abnormal_response/metabolism_ | 0.85199373 |
| 125 | MP0001664_abnormal_digestion | 0.84749262 |
| 126 | MP0002998_abnormal_bone_remodeling | 0.84617208 |
| 127 | MP0005623_abnormal_meninges_morphology | 0.84395770 |
| 128 | MP0006054_spinal_hemorrhage | 0.83625161 |
| 129 | MP0002229_neurodegeneration | 0.83190467 |
| 130 | MP0002295_abnormal_pulmonary_circulatio | 0.82846442 |
| 131 | * MP0005084_abnormal_gallbladder_morpholo | 0.81829678 |
| 132 | MP0002069_abnormal_eating/drinking_beha | 0.80968106 |
| 133 | MP0003634_abnormal_glial_cell | 0.80930681 |
| 134 | MP0003195_calcinosis | 0.79694292 |
| 135 | MP0010630_abnormal_cardiac_muscle | 0.79612047 |
| 136 | MP0005621_abnormal_cell_physiology | 0.79034500 |
| 137 | MP0004742_abnormal_vestibular_system | 0.78351817 |
| 138 | MP0002332_abnormal_exercise_endurance | 0.77179796 |
| 139 | MP0001544_abnormal_cardiovascular_syste | 0.76949122 |
| 140 | MP0005385_cardiovascular_system_phenoty | 0.76949122 |
| 141 | MP0003448_altered_tumor_morphology | 0.75477054 |
| 142 | MP0000358_abnormal_cell_content/ | 0.75373261 |
| 143 | MP0003300_gastrointestinal_ulcer | 0.74692642 |
| 144 | MP0002090_abnormal_vision | 0.74342323 |
| 145 | MP0003724_increased_susceptibility_to | 0.73444239 |
| 146 | MP0005620_abnormal_muscle_contractility | 0.73220244 |
| 147 | MP0005164_abnormal_response_to | 0.72797018 |
| 148 | MP0004947_skin_inflammation | 0.72145542 |
| 149 | MP0002118_abnormal_lipid_homeostasis | 0.71874884 |
| 150 | MP0002972_abnormal_cardiac_muscle | 0.71459898 |
| 151 | MP0010234_abnormal_vibrissa_follicle | 0.71070352 |
| 152 | MP0004036_abnormal_muscle_relaxation | 0.70229240 |
| 153 | MP0000249_abnormal_blood_vessel | 0.70113586 |
| 154 | MP0006035_abnormal_mitochondrial_morpho | 0.69510822 |
| 155 | MP0005384_cellular_phenotype | 0.69324533 |
| 156 | MP0004510_myositis | 0.68799674 |
| 157 | MP0000750_abnormal_muscle_regeneration | 0.68357994 |
| 158 | MP0005595_abnormal_vascular_smooth | 0.67849741 |
| 159 | MP0005448_abnormal_energy_balance | 0.67748220 |
| 160 | MP0005409_darkened_coat_color | 0.67575217 |
| 161 | MP0005165_increased_susceptibility_to | 0.67480067 |
| 162 | MP0004883_abnormal_blood_vessel | 0.67340794 |
| 163 | MP0001502_abnormal_circadian_rhythm | 0.67186116 |
| 164 | MP0006036_abnormal_mitochondrial_physio | 0.63615044 |
| 165 | MP0004145_abnormal_muscle_electrophysio | 0.61772478 |
| 166 | MP0001986_abnormal_taste_sensitivity | 0.59802057 |
| 167 | MP0001188_hyperpigmentation | 0.59417772 |
| 168 | MP0001765_abnormal_ion_homeostasis | 0.58357837 |
| 169 | MP0005166_decreased_susceptibility_to | 0.58147606 |
| 170 | MP0005058_abnormal_lysosome_morphology | 0.57224852 |
| 171 | MP0002152_abnormal_brain_morphology | 0.56583425 |
| 172 | MP0005171_absent_coat_pigmentation | 0.55395382 |
| 173 | MP0003137_abnormal_impulse_conducting | 0.55107284 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.56482239 |
| 2 | Focal motor seizures (HP:0011153) | 5.29994796 |
| 3 | Acute necrotizing encephalopathy (HP:0006965) | 4.07639102 |
| 4 | Atonic seizures (HP:0010819) | 3.95772453 |
| 5 | Vertebral compression fractures (HP:0002953) | 3.85295564 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.73506781 |
| 7 | Focal seizures (HP:0007359) | 3.66522599 |
| 8 | Mitochondrial inheritance (HP:0001427) | 3.63945113 |
| 9 | Progressive macrocephaly (HP:0004481) | 3.53618822 |
| 10 | Acute encephalopathy (HP:0006846) | 3.40876913 |
| 11 | Epileptic encephalopathy (HP:0200134) | 3.38385896 |
| 12 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.37101345 |
| 13 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.37101345 |
| 14 | Abnormality of glycolipid metabolism (HP:0010969) | 3.37101345 |
| 15 | Visual hallucinations (HP:0002367) | 3.31448506 |
| 16 | Absence seizures (HP:0002121) | 3.24367486 |
| 17 | Axonal loss (HP:0003447) | 3.18319392 |
| 18 | Hepatocellular necrosis (HP:0001404) | 3.14682405 |
| 19 | Pheochromocytoma (HP:0002666) | 3.12688108 |
| 20 | Distal lower limb muscle weakness (HP:0009053) | 3.01628814 |
| 21 | Generalized tonic-clonic seizures (HP:0002069) | 3.01292204 |
| 22 | Increased mean platelet volume (HP:0011877) | 2.99626801 |
| 23 | Neuroendocrine neoplasm (HP:0100634) | 2.98452429 |
| 24 | Retinal dysplasia (HP:0007973) | 2.97653710 |
| 25 | Anxiety (HP:0000739) | 2.97643560 |
| 26 | Purpura (HP:0000979) | 2.96088358 |
| 27 | Distal lower limb amyotrophy (HP:0008944) | 2.95459132 |
| 28 | Increased CSF lactate (HP:0002490) | 2.92383230 |
| 29 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.88337964 |
| 30 | Osteolytic defects of the hand bones (HP:0009699) | 2.88337964 |
| 31 | Neurofibrillary tangles (HP:0002185) | 2.85372701 |
| 32 | Dialeptic seizures (HP:0011146) | 2.85300620 |
| 33 | Increased connective tissue (HP:0009025) | 2.81512768 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 2.79622072 |
| 35 | Loss of speech (HP:0002371) | 2.75739592 |
| 36 | Polycythemia (HP:0001901) | 2.72471713 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 2.72361460 |
| 38 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.72278770 |
| 39 | Abnormal platelet volume (HP:0011876) | 2.72019622 |
| 40 | Protrusio acetabuli (HP:0003179) | 2.70581950 |
| 41 | Limb dystonia (HP:0002451) | 2.66005727 |
| 42 | Abnormal eating behavior (HP:0100738) | 2.64715282 |
| 43 | Hepatic necrosis (HP:0002605) | 2.58013448 |
| 44 | Abnormality of binocular vision (HP:0011514) | 2.57453418 |
| 45 | Diplopia (HP:0000651) | 2.57453418 |
| 46 | Lipid accumulation in hepatocytes (HP:0006561) | 2.54689495 |
| 47 | Petechiae (HP:0000967) | 2.53799726 |
| 48 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 2.50893240 |
| 49 | Increased variability in muscle fiber diameter (HP:0003557) | 2.49513637 |
| 50 | Febrile seizures (HP:0002373) | 2.49229656 |
| 51 | Nemaline bodies (HP:0003798) | 2.48599740 |
| 52 | Polyphagia (HP:0002591) | 2.45854923 |
| 53 | Menorrhagia (HP:0000132) | 2.45401268 |
| 54 | Renal Fanconi syndrome (HP:0001994) | 2.45070950 |
| 55 | Progressive cerebellar ataxia (HP:0002073) | 2.43991745 |
| 56 | Dysostosis multiplex (HP:0000943) | 2.43347396 |
| 57 | Parakeratosis (HP:0001036) | 2.39779376 |
| 58 | Progressive inability to walk (HP:0002505) | 2.39681731 |
| 59 | Increased intramyocellular lipid droplets (HP:0012240) | 2.39650403 |
| 60 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.37486818 |
| 61 | Torticollis (HP:0000473) | 2.36811365 |
| 62 | Broad-based gait (HP:0002136) | 2.35699722 |
| 63 | Cerebral hemorrhage (HP:0001342) | 2.33019208 |
| 64 | Rhabdomyolysis (HP:0003201) | 2.32150694 |
| 65 | Myotonia (HP:0002486) | 2.31591851 |
| 66 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.31086029 |
| 67 | Insomnia (HP:0100785) | 2.30820822 |
| 68 | Mutism (HP:0002300) | 2.29146071 |
| 69 | Cerebral edema (HP:0002181) | 2.29049140 |
| 70 | Papilledema (HP:0001085) | 2.29008813 |
| 71 | Amblyopia (HP:0000646) | 2.28415291 |
| 72 | Ankle clonus (HP:0011448) | 2.27606985 |
| 73 | Spinal rigidity (HP:0003306) | 2.27163293 |
| 74 | Diminished motivation (HP:0000745) | 2.26658046 |
| 75 | Cerebral inclusion bodies (HP:0100314) | 2.26545396 |
| 76 | Lower limb amyotrophy (HP:0007210) | 2.26513800 |
| 77 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.26482626 |
| 78 | Apathy (HP:0000741) | 2.26300913 |
| 79 | Focal dystonia (HP:0004373) | 2.25201934 |
| 80 | Prolonged bleeding time (HP:0003010) | 2.24679492 |
| 81 | Muscle fiber inclusion bodies (HP:0100299) | 2.22512536 |
| 82 | Action tremor (HP:0002345) | 2.22502860 |
| 83 | Dysmetria (HP:0001310) | 2.21543013 |
| 84 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.21282383 |
| 85 | Multiple enchondromatosis (HP:0005701) | 2.18956480 |
| 86 | Delusions (HP:0000746) | 2.18670296 |
| 87 | Craniofacial dystonia (HP:0012179) | 2.18398545 |
| 88 | Optic disc pallor (HP:0000543) | 2.17350781 |
| 89 | Depression (HP:0000716) | 2.15073490 |
| 90 | Type 1 muscle fiber predominance (HP:0003803) | 2.14807601 |
| 91 | Abnormal pupillary function (HP:0007686) | 2.14711688 |
| 92 | Poor suck (HP:0002033) | 2.13343865 |
| 93 | Respiratory failure (HP:0002878) | 2.11546290 |
| 94 | Premature rupture of membranes (HP:0001788) | 2.11393043 |
| 95 | Upper limb amyotrophy (HP:0009129) | 2.10787919 |
| 96 | Distal upper limb amyotrophy (HP:0007149) | 2.10787919 |
| 97 | Neck muscle weakness (HP:0000467) | 2.10088671 |
| 98 | Abnormality of the axillary hair (HP:0100134) | 2.09107841 |
| 99 | Abnormality of secondary sexual hair (HP:0009888) | 2.09107841 |
| 100 | Poor eye contact (HP:0000817) | 2.08600714 |
| 101 | Increased muscle lipid content (HP:0009058) | 2.08178734 |
| 102 | Back pain (HP:0003418) | 2.06916440 |
| 103 | Type II lissencephaly (HP:0007260) | 2.06634710 |
| 104 | Hyperparathyroidism (HP:0000843) | 2.05534982 |
| 105 | Truncal ataxia (HP:0002078) | 2.05048203 |
| 106 | Leukodystrophy (HP:0002415) | 2.04440132 |
| 107 | Myoglobinuria (HP:0002913) | 2.03923218 |
| 108 | Abnormal gallbladder physiology (HP:0012438) | 2.03892204 |
| 109 | Cholecystitis (HP:0001082) | 2.03892204 |
| 110 | Hyperventilation (HP:0002883) | 2.03017719 |
| 111 | Systemic lupus erythematosus (HP:0002725) | 2.02788353 |
| 112 | Lactic acidosis (HP:0003128) | 2.01561427 |
| 113 | Vascular tortuosity (HP:0004948) | 2.01352133 |
| 114 | Myocardial infarction (HP:0001658) | 2.01041784 |
| 115 | Growth hormone excess (HP:0000845) | 2.00332626 |
| 116 | Hemiparesis (HP:0001269) | 2.00330759 |
| 117 | Exercise intolerance (HP:0003546) | 1.99673328 |
| 118 | Ankle contracture (HP:0006466) | 1.99051910 |
| 119 | Hyperacusis (HP:0010780) | 1.99017223 |
| 120 | Abnormal hemoglobin (HP:0011902) | 1.98057335 |
| 121 | Hypothermia (HP:0002045) | 1.97648758 |
| 122 | Upper limb muscle weakness (HP:0003484) | 1.96588143 |
| 123 | Progressive neurologic deterioration (HP:0002344) | 1.96497159 |
| 124 | Hepatosplenomegaly (HP:0001433) | 1.94959039 |
| 125 | Ventricular fibrillation (HP:0001663) | 1.94806157 |
| 126 | Psychosis (HP:0000709) | 1.94803039 |
| 127 | Increased cerebral lipofuscin (HP:0011813) | 1.94353704 |
| 128 | Mitral stenosis (HP:0001718) | 1.92952885 |
| 129 | Neuronal loss in central nervous system (HP:0002529) | 1.92811704 |
| 130 | Abnormality of the Achilles tendon (HP:0005109) | 1.92577907 |
| 131 | Subcapsular cataract (HP:0000523) | 1.91140546 |
| 132 | Hypertriglyceridemia (HP:0002155) | 1.90915166 |
| 133 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.90127438 |
| 134 | Muscle hypertrophy of the lower extremities (HP:0008968) | 1.89954874 |
| 135 | Achilles tendon contracture (HP:0001771) | 1.88608582 |
| 136 | X-linked dominant inheritance (HP:0001423) | 1.88587702 |
| 137 | Papillary thyroid carcinoma (HP:0002895) | 1.88164246 |
| 138 | Agitation (HP:0000713) | 1.87179260 |
| 139 | Foot dorsiflexor weakness (HP:0009027) | 1.86596162 |
| 140 | Arterial tortuosity (HP:0005116) | 1.86516814 |
| 141 | Delayed gross motor development (HP:0002194) | 1.85377214 |
| 142 | Cholelithiasis (HP:0001081) | 1.83960418 |
| 143 | Failure to thrive in infancy (HP:0001531) | 1.82408657 |
| 144 | Hyperphosphaturia (HP:0003109) | 1.82332905 |
| 145 | Oligomenorrhea (HP:0000876) | 1.81705415 |
| 146 | Sensory axonal neuropathy (HP:0003390) | 1.81147712 |
| 147 | Exercise-induced myalgia (HP:0003738) | 1.81092763 |
| 148 | Increased serum pyruvate (HP:0003542) | 1.79053426 |
| 149 | Acanthosis nigricans (HP:0000956) | 1.78908100 |
| 150 | 3-Methylglutaconic aciduria (HP:0003535) | 1.78688854 |
| 151 | Amyloidosis (HP:0011034) | 1.78484508 |
| 152 | Hyporeflexia of lower limbs (HP:0002600) | 1.77775828 |
| 153 | Abnormal social behavior (HP:0012433) | 1.77510739 |
| 154 | Impaired social interactions (HP:0000735) | 1.77510739 |
| 155 | Mucopolysacchariduria (HP:0008155) | 1.76797193 |
| 156 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.76797193 |
| 157 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.76369262 |
| 158 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.76369262 |
| 159 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.76369262 |
| 160 | Bundle branch block (HP:0011710) | 1.75158283 |
| 161 | Rapidly progressive (HP:0003678) | 1.74969724 |
| 162 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.74484511 |
| 163 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.74484511 |
| 164 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.74337041 |
| 165 | Bulbar palsy (HP:0001283) | 1.74316732 |
| 166 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.73193674 |
| 167 | Ventricular tachycardia (HP:0004756) | 1.73098954 |
| 168 | Abnormal cartilage morphology (HP:0002763) | 1.72992730 |
| 169 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.70708879 |
| 170 | Tetraparesis (HP:0002273) | 1.70484390 |
| 171 | Fasciculations (HP:0002380) | 1.70367675 |
| 172 | Hand muscle atrophy (HP:0009130) | 1.70101026 |
| 173 | Muscle fiber splitting (HP:0003555) | 1.69884142 |
| 174 | Calf muscle hypertrophy (HP:0008981) | 1.69666981 |
| 175 | Cervical subluxation (HP:0003308) | 1.69385159 |
| 176 | Frequent falls (HP:0002359) | 1.68873675 |
| 177 | Intention tremor (HP:0002080) | 1.68240341 |
| 178 | Disinhibition (HP:0000734) | 1.68179154 |
| 179 | Personality changes (HP:0000751) | 1.67901578 |
| 180 | Inability to walk (HP:0002540) | 1.67750767 |
| 181 | Resting tremor (HP:0002322) | 1.67365424 |
| 182 | Emotional lability (HP:0000712) | 1.66448941 |
| 183 | Incomplete penetrance (HP:0003829) | 1.66323503 |
| 184 | Autoamputation (HP:0001218) | 1.65781501 |
| 185 | Difficulty climbing stairs (HP:0003551) | 1.65649952 |
| 186 | Generalized myoclonic seizures (HP:0002123) | 1.64213596 |
| 187 | Sudden death (HP:0001699) | 1.64120724 |
| 188 | Insidious onset (HP:0003587) | 1.64088648 |
| 189 | Termporal pattern (HP:0011008) | 1.64088648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K12 | 3.42368124 |
| 2 | EPHA4 | 3.21134933 |
| 3 | NTRK3 | 3.05814901 |
| 4 | MAP3K9 | 2.92318978 |
| 5 | EIF2AK1 | 2.85014535 |
| 6 | ARAF | 2.63105260 |
| 7 | MARK1 | 2.41632489 |
| 8 | CASK | 2.41632441 |
| 9 | MINK1 | 2.40597707 |
| 10 | TESK2 | 2.39630908 |
| 11 | TRIB3 | 2.32428656 |
| 12 | IRAK3 | 2.23193085 |
| 13 | DAPK2 | 2.18199751 |
| 14 | NME1 | 2.13888044 |
| 15 | MAP2K7 | 2.11587620 |
| 16 | RIPK4 | 2.07120416 |
| 17 | PBK | 2.06986022 |
| 18 | KSR2 | 2.00406707 |
| 19 | NTRK1 | 1.97714709 |
| 20 | DMPK | 1.96001088 |
| 21 | MAP3K4 | 1.95569226 |
| 22 | RIPK1 | 1.92896168 |
| 23 | BCR | 1.81956895 |
| 24 | MAP2K4 | 1.80252512 |
| 25 | TTN | 1.66612851 |
| 26 | GRK5 | 1.64435815 |
| 27 | LIMK1 | 1.61503260 |
| 28 | ABL2 | 1.54524966 |
| 29 | MAP3K6 | 1.54107013 |
| 30 | PAK4 | 1.51636329 |
| 31 | PAK6 | 1.50195490 |
| 32 | ILK | 1.49194195 |
| 33 | CDK19 | 1.48943736 |
| 34 | PDGFRA | 1.48058279 |
| 35 | OXSR1 | 1.46281858 |
| 36 | PRPF4B | 1.44490154 |
| 37 | CDK5 | 1.33906241 |
| 38 | PLK2 | 1.30913526 |
| 39 | KDR | 1.30315631 |
| 40 | BMX | 1.28699522 |
| 41 | CAMKK2 | 1.24879918 |
| 42 | TAOK2 | 1.24465008 |
| 43 | DAPK1 | 1.23158634 |
| 44 | KSR1 | 1.22548353 |
| 45 | SIK3 | 1.22390283 |
| 46 | MAP2K3 | 1.21528275 |
| 47 | STK39 | 1.21503808 |
| 48 | TGFBR2 | 1.21104992 |
| 49 | PTK2 | 1.17684935 |
| 50 | MAPK13 | 1.17163425 |
| 51 | MAP3K2 | 1.16758458 |
| 52 | NTRK2 | 1.15442839 |
| 53 | DAPK3 | 1.14033070 |
| 54 | PHKG1 | 1.09689896 |
| 55 | PHKG2 | 1.09689896 |
| 56 | MAP3K13 | 1.09363233 |
| 57 | FES | 1.08980369 |
| 58 | CAMK2A | 1.08779018 |
| 59 | EPHB1 | 1.07621266 |
| 60 | UHMK1 | 1.03634369 |
| 61 | DDR2 | 1.03562912 |
| 62 | NEK9 | 1.03090501 |
| 63 | PRKCG | 1.02954800 |
| 64 | CAMK2B | 1.01636931 |
| 65 | TESK1 | 0.99694506 |
| 66 | MAP3K3 | 0.99665884 |
| 67 | MYLK | 0.97357633 |
| 68 | GRK7 | 0.96744653 |
| 69 | CDK14 | 0.96313160 |
| 70 | MAP2K1 | 0.95096759 |
| 71 | LRRK2 | 0.95003589 |
| 72 | PAK3 | 0.92632465 |
| 73 | PTK2B | 0.90877834 |
| 74 | EPHA2 | 0.89668092 |
| 75 | MST1R | 0.87626079 |
| 76 | PAK2 | 0.85524058 |
| 77 | SIK1 | 0.85131942 |
| 78 | CDK18 | 0.84110358 |
| 79 | MAPKAPK5 | 0.83295415 |
| 80 | CAMKK1 | 0.82822437 |
| 81 | BMPR2 | 0.82647164 |
| 82 | TNIK | 0.81581510 |
| 83 | NME2 | 0.81226784 |
| 84 | WNK4 | 0.81062521 |
| 85 | PRKCE | 0.81032945 |
| 86 | PRKD3 | 0.80266772 |
| 87 | CDK15 | 0.77809290 |
| 88 | LMTK2 | 0.75823855 |
| 89 | ADRBK1 | 0.75719856 |
| 90 | CAMK2D | 0.75015416 |
| 91 | CSNK1G2 | 0.74332329 |
| 92 | TIE1 | 0.73672209 |
| 93 | PAK1 | 0.73283854 |
| 94 | CAMK2G | 0.72348462 |
| 95 | MOS | 0.70913034 |
| 96 | MAP3K11 | 0.70133559 |
| 97 | AKT3 | 0.69762534 |
| 98 | PNCK | 0.69463783 |
| 99 | MAP3K1 | 0.68664487 |
| 100 | PKN2 | 0.68447406 |
| 101 | CSNK1G3 | 0.67449863 |
| 102 | CDK11A | 0.66548635 |
| 103 | SIK2 | 0.65826525 |
| 104 | SGK223 | 0.62957343 |
| 105 | SGK494 | 0.62957343 |
| 106 | RAF1 | 0.62224698 |
| 107 | BMPR1B | 0.62115471 |
| 108 | TYK2 | 0.61413839 |
| 109 | ERN1 | 0.60982101 |
| 110 | MAPK12 | 0.60345767 |
| 111 | STK16 | 0.60151956 |
| 112 | MAP3K5 | 0.60037646 |
| 113 | BRAF | 0.59921612 |
| 114 | MAPKAPK3 | 0.59737418 |
| 115 | RET | 0.57194396 |
| 116 | BCKDK | 0.57124670 |
| 117 | ZAP70 | 0.56640545 |
| 118 | ROCK2 | 0.54978922 |
| 119 | ICK | 0.54756409 |
| 120 | FGR | 0.53409454 |
| 121 | ADRBK2 | 0.53269843 |
| 122 | CAMK1 | 0.51539280 |
| 123 | TAOK1 | 0.50941601 |
| 124 | TBK1 | 0.50616860 |
| 125 | AKT2 | 0.50482763 |
| 126 | DYRK2 | 0.50070346 |
| 127 | TYRO3 | 0.49564769 |
| 128 | NEK1 | 0.49561623 |
| 129 | EPHB2 | 0.47389538 |
| 130 | LATS2 | 0.46893422 |
| 131 | ERBB4 | 0.43581567 |
| 132 | RPS6KA2 | 0.43256612 |
| 133 | MST4 | 0.43145609 |
| 134 | PRKD1 | 0.42942243 |
| 135 | FER | 0.42363705 |
| 136 | PDPK1 | 0.42116710 |
| 137 | FGFR4 | 0.41664818 |
| 138 | ROCK1 | 0.40144424 |
| 139 | PRKACA | 0.40137868 |
| 140 | MAP2K6 | 0.39720185 |
| 141 | PRKCZ | 0.38742796 |
| 142 | SCYL2 | 0.38526818 |
| 143 | FYN | 0.37965566 |
| 144 | PIM2 | 0.37558847 |
| 145 | PDK2 | 0.35914761 |
| 146 | PDK4 | 0.35813013 |
| 147 | PDK3 | 0.35813013 |
| 148 | ALK | 0.30254948 |
| 149 | OBSCN | 0.29784482 |
| 150 | PTK6 | 0.29743941 |
| 151 | JAK1 | 0.29648109 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.87285571 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.28904130 |
| 3 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.21277058 |
| 4 | Alzheimers disease_Homo sapiens_hsa05010 | 2.71631144 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.66516092 |
| 6 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.64696151 |
| 7 | Nicotine addiction_Homo sapiens_hsa05033 | 2.59949874 |
| 8 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.45678345 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.28774636 |
| 10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.23359776 |
| 11 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 2.18218271 |
| 12 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 2.18118960 |
| 13 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.16077547 |
| 14 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.12915474 |
| 15 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.10376973 |
| 16 | Huntingtons disease_Homo sapiens_hsa05016 | 2.03486726 |
| 17 | Morphine addiction_Homo sapiens_hsa05032 | 1.90595743 |
| 18 | Circadian entrainment_Homo sapiens_hsa04713 | 1.89038482 |
| 19 | Olfactory transduction_Homo sapiens_hsa04740 | 1.88342157 |
| 20 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.83612738 |
| 21 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.83225352 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.79582580 |
| 23 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.74683818 |
| 24 | Long-term potentiation_Homo sapiens_hsa04720 | 1.74664145 |
| 25 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.74166229 |
| 26 | Protein export_Homo sapiens_hsa03060 | 1.72369245 |
| 27 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.71503281 |
| 28 | Other glycan degradation_Homo sapiens_hsa00511 | 1.70102124 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.68146690 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.62296506 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.60299510 |
| 32 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.60023996 |
| 33 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.55662278 |
| 34 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.53860649 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.52737886 |
| 36 | Salivary secretion_Homo sapiens_hsa04970 | 1.50897782 |
| 37 | Insulin secretion_Homo sapiens_hsa04911 | 1.48259101 |
| 38 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.46623459 |
| 39 | Cocaine addiction_Homo sapiens_hsa05030 | 1.41309334 |
| 40 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.40021611 |
| 41 | Ribosome_Homo sapiens_hsa03010 | 1.38179201 |
| 42 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.36522661 |
| 43 | Renin secretion_Homo sapiens_hsa04924 | 1.35914793 |
| 44 | Long-term depression_Homo sapiens_hsa04730 | 1.32805186 |
| 45 | * SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.31924655 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 1.30721608 |
| 47 | Taste transduction_Homo sapiens_hsa04742 | 1.27352915 |
| 48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.22533218 |
| 49 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.20181632 |
| 50 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18668520 |
| 51 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.17729295 |
| 52 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.14419163 |
| 53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.13935397 |
| 54 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.12510495 |
| 55 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12372486 |
| 56 | Platelet activation_Homo sapiens_hsa04611 | 1.09081706 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.07833201 |
| 58 | Focal adhesion_Homo sapiens_hsa04510 | 1.06073814 |
| 59 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.06025718 |
| 60 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.03644599 |
| 61 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.03614280 |
| 62 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.02919054 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 1.01541530 |
| 64 | Thyroid cancer_Homo sapiens_hsa05216 | 1.01509027 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.00748849 |
| 66 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00163102 |
| 67 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.99642938 |
| 68 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.99075398 |
| 69 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.98921562 |
| 70 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.98762500 |
| 71 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.91181215 |
| 72 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.91127043 |
| 73 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.91053477 |
| 74 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.90636300 |
| 75 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.87468465 |
| 76 | Adherens junction_Homo sapiens_hsa04520 | 0.87390512 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.86832902 |
| 78 | Phagosome_Homo sapiens_hsa04145 | 0.86830676 |
| 79 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.85650800 |
| 80 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.84543303 |
| 81 | Proteasome_Homo sapiens_hsa03050 | 0.82992609 |
| 82 | Sulfur relay system_Homo sapiens_hsa04122 | 0.79099291 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.78632717 |
| 84 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76759150 |
| 85 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.76103242 |
| 86 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.74368065 |
| 87 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.73218602 |
| 88 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.73212960 |
| 89 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.73084783 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.72358257 |
| 91 | Tight junction_Homo sapiens_hsa04530 | 0.72211032 |
| 92 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.72004034 |
| 93 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.71042448 |
| 94 | Endometrial cancer_Homo sapiens_hsa05213 | 0.70999679 |
| 95 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.69047890 |
| 96 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.69031454 |
| 97 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.67704108 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65919044 |
| 99 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.65775825 |
| 100 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.65635192 |
| 101 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.64726559 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.64563212 |
| 103 | Amoebiasis_Homo sapiens_hsa05146 | 0.64475773 |
| 104 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.63500950 |
| 105 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.62004489 |
| 106 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.61520719 |
| 107 | Melanogenesis_Homo sapiens_hsa04916 | 0.59596353 |
| 108 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.58970984 |
| 109 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.58853218 |
| 110 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.58717426 |
| 111 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.58031729 |
| 112 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.57304556 |
| 113 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.56554976 |
| 114 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.56293405 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.55634089 |
| 116 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.55364961 |
| 117 | Prion diseases_Homo sapiens_hsa05020 | 0.54131146 |
| 118 | Hepatitis C_Homo sapiens_hsa05160 | 0.53181469 |
| 119 | Axon guidance_Homo sapiens_hsa04360 | 0.52800386 |
| 120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.52170804 |
| 121 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.51464384 |
| 122 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.50319737 |
| 123 | Phototransduction_Homo sapiens_hsa04744 | 0.48527241 |
| 124 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.47772039 |
| 125 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.47202591 |
| 126 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.46896309 |
| 127 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.46812152 |
| 128 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.46082441 |
| 129 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.45813183 |
| 130 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.45758137 |
| 131 | Malaria_Homo sapiens_hsa05144 | 0.45000417 |
| 132 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.44335309 |
| 133 | Peroxisome_Homo sapiens_hsa04146 | 0.44060618 |
| 134 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43419681 |
| 135 | Pertussis_Homo sapiens_hsa05133 | 0.42827631 |
| 136 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.42731371 |
| 137 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42689397 |
| 138 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.42638104 |
| 139 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.42143808 |
| 140 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.41286071 |
| 141 | Endocytosis_Homo sapiens_hsa04144 | 0.41209510 |
| 142 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.41188137 |
| 143 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.41005397 |
| 144 | Glioma_Homo sapiens_hsa05214 | 0.40130598 |
| 145 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.39381521 |
| 146 | Bile secretion_Homo sapiens_hsa04976 | 0.38048192 |
| 147 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.37372085 |
| 148 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.35632124 |
| 149 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.35539992 |
| 150 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34759480 |
| 151 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.34476183 |
| 152 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.34198871 |
| 153 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.33380589 |
| 154 | Mineral absorption_Homo sapiens_hsa04978 | 0.32852008 |
| 155 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.32799535 |
| 156 | Salmonella infection_Homo sapiens_hsa05132 | 0.32644593 |
| 157 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.30766693 |
| 158 | Lysosome_Homo sapiens_hsa04142 | 0.30642757 |
| 159 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.26815227 |
| 160 | Alcoholism_Homo sapiens_hsa05034 | 0.26429457 |
| 161 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24783523 |
| 162 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.23938988 |
| 163 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.22766850 |
| 164 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.21931207 |
| 165 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.21536048 |
| 166 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.21437787 |
| 167 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.20435584 |
| 168 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.20176917 |

